Citation: F. Lejeune et al., REGIONAL ADMINISTRATION OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA INCANCER, WITH SPECIAL REFERENCE TO MELANOMA, Biodrugs, 9(3), 1998, pp. 211-218
Authors:
GROSSHANS E
BASTUJI S
CHAGNON S
DROZ JP
EVEILLARD P
GROSSHANS D
GUILLOT B
LABEILLE B
LEBOLLOCH A
LITOUX P
LORETTE G
MARTIN D
SEI JF
BELAICH S
BONERANDI JJ
CESARINI JP
COUILLIET D
DELAUNAY M
DRENO B
EGGERMONT A
GROB J
LIENARD D
NICOLAS J
POISSONSALOMON A
REVUZ J
SAURAT JH
SIGAL R
WEIL M
CHARTIER C
FORTIERBEAULIEU M
GAUTIERGOUGIS MS
GRANGE F
RICHARD MA
THOMAS L
TRUCHETET F
Citation: E. Grosshans et al., CONSENSUS CONFERENCE - MONITORING PATIENT S AFTER SURGERY FOR STAGE-IMALIGNANT-MELANOMA, La Semaine des hopitaux de Paris, 74(11-12), 1998, pp. 577-587
Authors:
GERAIN J
LIENARD D
PAMPALLONA S
BAUMGARTNER M
RUEGG C
BUURMAN WA
EGGERMONT A
LEJEUNE F
Citation: J. Gerain et al., SYSTEMIC RELEASE OF SOLUBLE TNF RECEPTORS AFTER HIGH-DOSE TNF IN ISOLATED LIMB PERFUSION, Cytokine, 9(12), 1997, pp. 1034-1042
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
KOOPS HS
ROSENKAIMER F
GERAIN J
KLAASE J
KROON B
SCHMITZ P
Citation: F. Lejeune et al., EFFICACY OF TUMOR-NECROSIS-FACTOR-ALPHA ( RTNF-ALPHA) ASSOCIATED TO INTERFERON-GAMMA (IFN-GAMMA) AND TO CHEMOTHERAPY IN ISOLATED LIMB PERFUSION FOR INOPERABLE MALIGNANT-MELANOMA, SOFT-TISSUE SARCOMA AND EPIDERMOID CARCINOMA - A 4-YEAR EXPERIENCE, Bulletin du cancer, 82(7), 1995, pp. 561-567
Authors:
VANDERHEYDEN S
GHEUENS E
VANDEVRIE W
VANBOCKSTAELE D
VANOOSTEROM A
EGGERMONT A
DEBRUIJN EA
Citation: S. Vanderheyden et al., 5'-DEOXY-5-FLUOROURIDINE INCREASES DAUNORUBICIN UPTAKE IN MULTIDRUG-RESISTANT CELLS AND ITS ACTIVITY IS RELATED WITH P-GP-170 EXPRESSION, Japanese journal of cancer research, 85(1), 1994, pp. 13-16
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
KOOPS HS
ROSENKAIMER F
GERAIN J
KLAASE J
KROON B
VANDERVEKEN J
SCHMITZ P
Citation: F. Lejeune et al., RATIONALE FOR USING TNF-ALPHA AND CHEMOTHERAPY IN REGIONAL THERAPY OFMELANOMA, Journal of cellular biochemistry, 56(1), 1994, pp. 52-61
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
KOOPS HS
KROON B
GERAIN J
ROSENKAIMER F
SCHMITZ P
Citation: F. Lejeune et al., CLINICAL-EXPERIENCE WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA IN REGIONAL THERAPY OF ADVANCED MELANOMA, Circulatory shock, 43(4), 1994, pp. 191-197
Authors:
RENARD N
LIENARD D
LESPAGNARD L
EGGERMONT A
HEIMANN R
LEJEUNE F
Citation: N. Renard et al., EARLY ENDOTHELIUM ACTIVATION AND POLYMORPHONUCLEAR CELL INVASION PRECEDE SPECIFIC NECROSIS OF HUMAN-MELANOMA AND SARCOMA TREATED BY INTRAVASCULAR HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA (RTNF-ALPHA), International journal of cancer, 57(5), 1994, pp. 656-663
Authors:
GHEUENS E
VANDERHEYDEN S
ELST H
EGGERMONT A
VANOOSTEROM A
DEBRUIJN E
Citation: E. Gheuens et al., MULTIDRUG-RESISTANCE IN RAT COLON-CARCINOMA CELL-LINES CC531, CC531(MDR+) AND CC531(REV), Japanese journal of cancer research, 84(11), 1993, pp. 1201-1208